🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Vegetable Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
29% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 600.0mg (7 products) 📚 39 studies (Tier A: 2, B: 13)
This product: 800mg
📊 Market median: 300.0mg (159 products)
Median 300.0mg This product: 400mg
📊 Market median: 250.0mg (562 products) 📚 53 studies (Tier A: 0, B: 19)
This product: 280mg
📊 Market median: 650.0mg (87 products) 📚 1 studies — no high-quality reviews
This product: 100mg
Phyllanthus amarus extract
100 mg
Uva Ursi
100 mg
Bupleurum root extract
50 mg

Other Ingredients

Cellulose Magnesium Stearate Silica

Label Claims — Verification

All Other
Structure/Function
All Other (96% of products) Structure/Function (81% of products) Nutrient (19% of products) No Claim (3% of products)

Target Groups

Children 4 or More Years of Age Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions for use: as a dietary supplement for adults and children twelve or more years of age, take three capsules per day, or as directed by a qualified healthcare professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

Tamper resistant. Do not purchase if seal is broken.

🧪 Formulation Notes

The ingredients found in Vinco’s Liver/Kidney Detox have been shown to be beneficial in support of liver and kidney detoxification.

Made in USA

Detoxification support

Gluten free

No wheat, no gluten, no corn, no dairy, no soy, yeast free

Additional Information

Store in a cool, dry place.

Professional formulation

Product Details

UPC / SKU 7 39930 27506 5
DSLD Entry Date 2023-08-23
Product Type Other Combinations
Form Capsule
Brand Vinco
DSLD ID 295256
Data Updated 2026-04-11

Research Evidence

41 Research Sources
51 Avg Quality Score
19 Rct
13 Meta Analysis
9 Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024
View all evidence for Nac →

Compare Similar Products

View all Nac products →